LABT
Lakewood-Amedex Biotherapeutics Inc. Common Stock NASDAQ$3.43
Mkt Cap $12.2M
52w Low $2.59
12.6% of range
52w High $9.26
50d MA $8.00
200d MA $8.00
P/E (TTM)
—
EV/EBITDA
—
P/B
—
Debt/Equity
—
ROE
—
P/FCF
—
RSI (14)
—
ATR (14)
—
Beta
0.00
50d MA
$8.00
200d MA
$8.00
Avg Volume
2.0M
About
Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 cli…
Data updated apr 25, 2026 6:21pm
· Source: massive.com